OncoNano Medicine
0 followers
OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeut... Read more
Org chart
Matthew Head
CFO
Don Kruppa
VP, Technical Operations
Kathy Rath
VP, Regulatory Affairs
Ruolan Han
VP, Nonclinical & Translational Medicine
Elina Lavit
VP, Business Development
Tian Zhao
VP, Research & Development
